Parschauer Karah Herdman (CIK 0001677455)

Latest company ownership

RARE - Ultragenyx Pharmaceutical Inc.
Role: EVP and Chief Legal Officer
Shares held
73,271
Last filed at
Sep 12, 2025
Confidence Score
45.4
2025Q4
Confidence Score History
2017Q2 2025Q4
EOLS - Evolus, Inc.
Role: Director
Shares held
32,183
Last filed at
Mar 14, 2025
Confidence Score
49.7
2025Q4
Confidence Score History
2024Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 12, 2025 Sep 12, 2025 Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Sell 22.5 -2,450 -3.24% ✗ $76.4K
Mar 12, 2025 Mar 14, 2025 Evolus, Inc. Director Sell 22.5 -12,888 -28.59% ✗ $167.5K
Mar 1, 2025 Mar 4, 2025 Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Sell 92.5 +5,597 8.03% ✗ $540.8K
Feb 27, 2025 Mar 3, 2025 Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Sell 90.0 +11,504 6.81% ✗ $128.2K
Jun 12, 2024 Jun 12, 2024 Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Sell 20.0 -9,806 -14.47% ✗ $441.3K
Mar 1, 2024 Mar 5, 2024 Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Sell 90.0 +15,001 7.78% ✗ $201.9K
Jan 30, 2024 Feb 2, 2024 Evolus, Inc. Director Sell 10.0 -11,931 -27.63% ✓ $156.7K
May 4, 2023 May 5, 2023 Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Sell 28.8 -4,378 -7.77% ✓ $197K
Mar 1, 2023 Mar 3, 2023 Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Sell 95.0 +21,502 16.43% ✗ $143K
Mar 7, 2022 Mar 8, 2022 Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Sell 20.0 -5,140 -12.99% ✗ $323.6K
Mar 1, 2022 Mar 3, 2022 Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Sell 95.0 +11,114 20.61% ✗ $192.3K
Oct 14, 2021 Oct 18, 2021 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 46.3 -310 -1.08% ✗ $25.2K
Sep 8, 2021 Sep 9, 2021 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 20.0 -7,336 -20.38% ✗ $738.4K
Jun 10, 2021 Jun 11, 2021 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 37.5 -1,329 -4.43% ✓ $132.9K
May 6, 2021 May 10, 2021 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 46.3 -313 -1.03% ✗ $35.6K
Mar 1, 2021 Mar 3, 2021 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 97.5 +6,166 25.63% ✗ $548.5K
Oct 30, 2020 Nov 2, 2020 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 7.5 -9,903 -29.16% ✓ $991.5K
Oct 28, 2020 Oct 30, 2020 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 53.8 -97 -0.40% ✓ $9.7K
Oct 14, 2020 Oct 16, 2020 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 46.3 -325 -1.34% ✗ $28.6K
Oct 8, 2020 Oct 13, 2020 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 7.5 -10,000 -29.16% ✓ $950K
Oct 6, 2020 Oct 7, 2020 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 7.5 -10,000 -29.16% ✓ $900K
Sep 23, 2020 Sep 24, 2020 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 7.5 -10,000 -29.16% ✓ $850K
Aug 17, 2020 Aug 19, 2020 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 17.5 -12,370 -33.74% ✗ $1.1M
Jun 20, 2020 Jun 22, 2020 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 42.5 -649 -2.38% ✗ $50.8K
May 18, 2020 May 19, 2020 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 22.5 -2,722 -9.06% ✗ $203.4K
May 6, 2020 May 8, 2020 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 48.8 -248 -0.82% ✗ $16.4K
Apr 19, 2020 Apr 21, 2020 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 48.8 -248 -0.82% ✗ $14.5K
Mar 1, 2020 Mar 3, 2020 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 95.0 +11,316 59.30% ✗ $118.8K
Jun 20, 2019 Jun 24, 2019 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 20.0 -3,364 -16.01% ✓ $210.4K
Apr 29, 2019 Apr 30, 2019 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 45.0 -468 -2.33% ✓ $32K
Apr 19, 2019 Apr 23, 2019 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 46.3 -248 -1.22% ✗ $16K
Mar 1, 2019 Apr 17, 2019 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 95.0 +6,114 43.11% ✗ $58.1K
Mar 1, 2019 Mar 4, 2019 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 95.0 +6,140 43.30% ✗ $58.1K
Aug 21, 2018 Oct 9, 2018 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 20.0 -5,000 -26.07% ✗ $392.7K
Aug 21, 2018 Aug 21, 2018 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 20.0 -5,000 -35.26% ✗ $392.7K
Jun 21, 2018 Jun 21, 2018 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 28.8 -1,226 -7.96% ✓ $101.5K
Jun 20, 2018 Jun 20, 2018 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 42.5 -649 -4.04% ✗ $55.4K
May 10, 2018 May 10, 2018 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 28.8 -1,465 -8.36% ✓ $87.9K
Mar 1, 2018 Mar 5, 2018 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 90.0 +7,295 82.94% ✗ $9.9K
Jun 20, 2017 Jun 21, 2017 Ultragenyx Pharmaceutical Inc. EVP and General Counsel Sell 46.3 -705 -7.42% ✗ $44.7K